← Eichor
Condition: Stable Neonates Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Stable Neonates

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Isoleucine, Leucine, Valine and Tryptophan Requirements in TPN Fed Neonates
NA · 1 location(s) · The Hospital for Sick Children · NCT06372314Phenylalanine, Methionine and Histidine Requirements in TPN Fed Neonates
NA · 1 location(s) · The Hospital for Sick Children · NCT05562310Escalating Doses of VAS-101 in Subjects With Stable Sickle Cell Disease
Phase 1 · 1 location(s) · National Heart, Lung, and Blood Institute (NHLBI) · NCT07566494Myocardialbridge Bypass Graft Surgery Efficacy Verification
NA · 1 location(s) · Xi'an International Medical Center Hospital · NCT06857838Effects of High Intensity Interval Training in Down Syndrome
NA · 1 location(s) · Riphah International University · NCT06777394FOG-001 in Locally Advanced or Metastatic Solid Tumors
Phase 1/Phase 2 · 33 location(s) · Parabilis Medicines, Inc. · NCT05919264Developmental Dysplasia of the Hip: Observation vs. Bracing
NA · 1 location(s) · University of British Columbia · NCT05869851Goat vs. Cow Milk Digestive Tolerance
NA · 1 location(s) · Institut National de Recherche pour l'Agriculture, l'Aliment · NCT07239856A Study to Investigate the Safety, Pharmacokinetics, and Preliminary Efficacy of IDE574 Therapy in Adult Participants Wi
Phase 1 · 11 location(s) · IDEAYA Biosciences · NCT07540572Effects of Pelvic Girdle Stabililty With Use of Therapeutic Taping in Down Syndrome
NA · 2 location(s) · Riphah International University · NCT06770218Study to Evaluate the Safety and Tolerability of Escalating Doses of Fostamatinib in Subjects With Stable Sickle Cell Di
Phase 1 · 1 location(s) · National Heart, Lung, and Blood Institute (NHLBI) · NCT05904093STABLE Pilates for Hypermobility
NA · 1 location(s) · Brigham and Women's Hospital · NCT07464093A Phase II Study of Sintilimab Combined With Ipilimumab N01, Cetuximab and Dabrafenib in Patients With Microsatellite-St
Phase 2 · 4 location(s) · Tianjin Medical University Cancer Institute and Hospital · NCT07506109Drug-Drug Interaction Study of ABP-671 in Gout Patients
Phase 1 · 1 location(s) · Atom Therapeutics Co., Ltd · NCT07367971
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.